EUVIMEDEUVIMED entdecken
Open Access

Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer

Behnaz Babaye Abdollahi iD, Marjan Ghorbani, Hamed Hamishehkar, Reza Malekzadeh, Alireza Farajollahi iD

BioImpacts · 01.01.2023 · 13 (1) · 17-29

DOI: 10.34172/bi.2022.23682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioImpacts, online erschienen am 15.01.2022. Verfasst von Behnaz Babaye Abdollahi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The present study was done to assess the effect of molecularly-targeted core/shell of iron oxide/gold nanoparticles (Fe3O4@AuNPs) on tumor radiosensitization of SKBr-3 breast cancer cells.

Methods

Human epidermal growth factor receptor-2 (HER-2)-targeted Fe3O4@AuNPs were synthesized by conjugating trastuzumab (TZ, Herceptin) to PEGylated (PEG)-Fe3O4@AuNPs (41.5 nm). First, the Fe3O4@Au core-shell NPs were decorated with PEG-SH to synthesize PEG-Fe3O4@AuNPs. Then, the TZ was reacted to OPSS-PEG-SVA to conjugate with the PEG-Fe3O4@AuNPs. As a result, structure, size and morphology of the developed NPs were assessed using Fourier-transform infrared (FT-IR) spectroscopy, dynamic light scattering (DLS) and transmission electron microscopy (TEM), and ultraviolet-visible spectroscopy. The SKBr-3 cells were treated with different concentrations of TZ, Fe3O4@Au, and TZ-PEG-Fe3O4@AuNPs for irradiation at doses of 2, 4, and 8 Gy (from X-ray energy of 6 and 18 MV). Cytotoxicity was assessed by MTT assay, BrdU assay, and flow cytometry.

Results

Results showed that the targeted TZ-PEG-Fe3O4@AuNPs significantly improved cell uptake. The cytotoxic effects of all the studied groups were increased in a higher concentration, radiation dose and energy-dependent manner. A combination of TZ, Fe3O4@Au, and TZ-PEG-Fe3O4@AuNPs with radiation reduced cell viability by 1.35 (P=0.021), 1.95 (P=0.024), and 1.15 (P=0.013) in comparison with 8 Gy dose of 18 MV radiation alone, respectively. These amounts were obtained as 1.27, 1.58, and 1.10 for 8 Gy dose of 6 MV irradiation, respectively.

Conclusion

Radiosensitization of breast cancer to mega-voltage radiation therapy with TZ-PEG-Fe3O4@AuNPs was successfully obtained through an optimized therapeutic approach for molecular targeting of HER-2.

Schlagwörter

Stichwörter der Autor:innen

Active targetingAu nanoparticlesBreast cancerRadiation therapyTrastuzumab

Autor:innen und Institutionen

  • Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Nutration Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Imam Reza Educational Hospital, Radiotherapy Department, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Behnaz Babaye Abdollahi, Alireza Farajollahi

Zitieren

APA

Babaye Abdollahi, B., Ghorbani, M., Hamishehkar, H., Malekzadeh, R., & Farajollahi, A. (2023). Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer. BioImpacts, 13(1), 17-29. https://doi.org/10.34172/bi.2022.23682

Vancouver

Babaye Abdollahi B, Ghorbani M, Hamishehkar H, Malekzadeh R, Farajollahi A. Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer. BioImpacts. 2023;13(1):17-29. doi:10.34172/bi.2022.23682

BibTeX
@article{BabayeAbdollahi2023,
  author = {Babaye Abdollahi, Behnaz and Ghorbani, Marjan and Hamishehkar, Hamed and Malekzadeh, Reza and Farajollahi, Alireza},
  title = {Synthesis and characterization of actively HER-2 Targeted Fe 3 O 4 @Au nanoparticles for molecular radiosensitization of breast cancer},
  journal = {BioImpacts},
  year = {2023},
  volume = {13},
  number = {1},
  pages = {17--29},
  doi = {10.34172/bi.2022.23682}
}
Kostenlos starten →